$AZN #AstraZeneca ASTRAZENECA: AZ said to have approached Gilead to discuss a merger | BUY vs. BUY - TOP PICKS | 9100p(+7%): ASTRAZENECA - BUY vs. BUY - TOP PICKS | 9100p(+7%) AZ said to have approached Gilead to discuss a merger At first… https://t.co/Kk9ptgUb86 #equity #stocks https://t.co/cTjZbCkZ1i